Home › Endometrial Cancer › Montana › Kalispell
Endometrial Cancer clinical trials in Kalispell, MT
4 studies for Endometrial Cancer are looking for participants at sites in and around Kalispell (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Logan Health Medical Center, Kalispell
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
- Logan Health Medical Center, Kalispell
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Logan Health Medical Center, Kalispell
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Logan Health Medical Center, Kalispell
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Chicago, IL26 studies
- Queens, NY26 studies
Other studies in Kalispell
- Non-Small Cell Lung Cancer9 studies
- Prostate Cancer8 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia6 studies
- Melanoma5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Colorectal Cancer4 studies
- Bladder Cancer4 studies
- Colon Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Breast Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.